AXIN2-Associated Adenomatous Colorectal Polyposis
Abstract Introduction Most cases of colorectal cancer (CRC) occur sporadically; however, ∼ 3% to 6% of all CRCs are related to inherited syndromes, such as Lynch syndrome and familial adenomatous polyposis (FAP). The adenomatous polyposis coli ( APC ) and mutY DNA glycosylase ( MUTYH ) germline mut...
Saved in:
Published in | Journal of Coloproctology Vol. 41; no. 4; pp. 443 - 446 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
Thieme Revinter Publicações Ltda
01.12.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract
Introduction
Most cases of colorectal cancer (CRC) occur sporadically; however, ∼ 3% to 6% of all CRCs are related to inherited syndromes, such as Lynch syndrome and familial adenomatous polyposis (FAP). The adenomatous polyposis coli (
APC
) and mutY DNA glycosylase (
MUTYH
) germline mutations are the main genetic causes related to colorectal polyposis. Nevertheless, in many cases mutations in these genes have not been identified. The aim of the present case report is to describe a rare case of genetic colorectal polyposis associated with the axis inhibition protein 2 (
AXIN2
) gene.
Case Report
The first colonoscopy screening of a 61-year-old male patient with no known family history of CRC revealed ∼ 50 colorectal polyps. A histological evaluation of the resected polyps showed low-grade tubular adenomas. Germline genetic testing through a multigene panel for cancer predisposition syndromes revealed a pathogenic variant in the
AXIN2
gene. In addition to colorectal polyposis, the patient had mild features of ectodermal dysplasia: hypodontia, scant body hair, and onychodystrophy.
Discussion
The
AXIN2
gene acts as a negative regulator of the Wnt/β -catenin signaling pathway, which participates in development processes and cellular homeostasis. Further studies are needed to support the surveillance recommendations for carriers of the
AXIN2
pathogenic variant. |
---|---|
ISSN: | 2237-9363 2317-6423 |
DOI: | 10.1055/s-0041-1732328 |